BioCentury
ARTICLE | Company News

Amrad, CAT rheumatoid arthritis deal

December 19, 2001 8:00 AM UTC

Cambridge Antibody Technology (LSE:CAT; CATG) and cytokine biology play Amrad (ASX:AML) partnered to develop human antibodies to treat rheumatoid arthritis through neutralization of the receptor for g...